Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5956 AL 5970

A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease

Frakey LL, Salloway S, Buelow M, Malloy P.

J Clin Psychiatry. 2012 Jun;73(6):796-801. doi: 10.4088/JCP.10m06708. Epub 2012 May 15.

A rivastigmine-precipitated manic episode in a patient with Alzheimer-type dementia

Tseng WS, Tzeng NS.

Int Psychogeriatr. 2012 Oct;24(10):1697-9. doi: 10.1017/S1041610212000701. Epub 2012 Apr 26.

Amyloid plaque imaging from IMPY/SPECT to AV-45/PET

Kung MP, Weng CC, Lin KJ, Hsiao IT, Yen TC, Wey SP.

Chang Gung Med J. 2012 May-Jun;35(3):211-8. doi: 10.4103/2319-4170.106151.

Worldwide Alzheimer's disease neuroimaging initiative

Carrillo MC, Bain LJ, Frisoni GB, Weiner MW.

Alzheimers Dement. 2012 Jul;8(4):337-42. doi: 10.1016/j.jalz.2012.04.007.

Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer's disease

Sanchez-Ramos J, Cimino C, Avila R, Rowe A, Chen R, Whelan G, Lin X, Cao C, Ashok R.

J Alzheimers Dis. 2012;31(4):843-55. doi: 10.3233/JAD-2012-120196.

The neurobiology of Alzheimer disease defined by neuroimaging

Masdeu JC, Kreisl WC, Berman KF.

Curr Opin Neurol. 2012 Aug;25(4):410-20. doi: 10.1097/WCO.0b013e3283557b36.

[There's not only Alzheimer's disease]

Nardi M, Anwander M, Rüegger-Frey B, Bopp-Kistler I.

Praxis (Bern 1994). 2012 Jul 25;101(15):977-81. doi: 10.1024/1661-8157/a001006.

Solving the puzzle of Alzheimer disease

Uriri-Glover J, McCarthy M, Cesarotti E.

Nurse Pract. 2012 Sep 10;37(9):20-7; quiz 27-8. doi: 10.1097/01.NPR.0000418381.60864.68.

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S, Shiovitz T, Pilcher G, Colby S, Rollin L, Dockens R, Pachai C, Portelius E, Andreasson U, Blennow K, Soares H, Albright C, Feldman HH, Berman RM.

Arch Neurol. 2012 Nov;69(11):1430-40. doi: 10.1001/archneurol.2012.2194.

The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results

Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.

J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7.

Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease

Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; Depression in Alzheimer’s Disease Study–2 Research Group.

Am J Geriatr Psychiatry. 2012 Dec;20(12):1036-44. doi: 10.1097/JGP.0b013e31826ce4c5.

Potential of drug-loaded nanoparticles for Alzheimer's disease: diagnosis, prevention and treatment

Doggui S, Dao L, Ramassamy C.

Ther Deliv. 2012 Sep;3(9):1025-7. doi: 10.4155/tde.12.84.

Effect of cholinesterase inhibitors on attention

Pepeu G, Giovannini MG, Bracco L.

Chem Biol Interact. 2013 Mar 25;203(1):361-4. doi: 10.1016/j.cbi.2012.09.016. Epub 2012 Oct 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias